Cargando…
Revealing the Threat of Emerging SARS-CoV-2 Mutations to Antibody Therapies
The ongoing massive vaccination and the development of effective intervention offer the long-awaited hope to end the global rage of the COVID-19 pandemic. However, the rapidly growing SARS-CoV-2 variants might compromise existing vaccines and monoclonal antibody (mAb) therapies. Although there are v...
Autores principales: | Chen, Jiahui, Gao, Kaifu, Wang, Rui, Wei, Guo-Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277955/ https://www.ncbi.nlm.nih.gov/pubmed/34273397 http://dx.doi.org/10.1016/j.jmb.2021.167155 |
Ejemplares similares
-
Prediction and mitigation of mutation threats to COVID-19 vaccines and antibody therapies
por: Chen, Jiahui, et al.
Publicado: (2021) -
Characterizing SARS-CoV-2 mutations in the United States
por: Wang, Rui, et al.
Publicado: (2020) -
Analysis of SARS-CoV-2 mutations in the United States suggests presence of four substrains and novel variants
por: Wang, Rui, et al.
Publicado: (2021) -
Author Correction: Analysis of SARS-CoV-2 mutations in the United States suggests presence of four substrains and novel variants
por: Wang, Rui, et al.
Publicado: (2021) -
Mutations Strengthened SARS-CoV-2 Infectivity
por: Chen, Jiahui, et al.
Publicado: (2020)